Table 1.
Summary of reported cases of liver carcinosarcoma with combined hepatocellular cholangiocarcinoma
| Ref. | Age (yr) | Sex | Positive tumor marker | HBV | HCV | Cirrhosis | Size (cm) | Sarcoma element | Treatment | Metastasis | Outcome |
| Nakajima et al[2] | 74 | M | - | - | NA | Precirrhotic fibrosis | 15 × 13 | Pleomorphic cells, spindle shaped cells, and osteoplastic cells | Mitomycin C | Liver, lung, lymph nodes, stomach, peritoneum | Died within 5 mo |
| Papotti et al[3] | 59 | M | - | - | - | - | 4.0 × 5.2 | Spindle cells | Right hepatectomy | PVTT | Died within 4 mo |
| Goto et al[1] | 73 | M | AFP | + | NA | + | 3 × 2.5 × 2 | Chondrosarcoma, osteosarcoma | Segmentectomy | - | 19 mo, alive |
| CEA | |||||||||||
| CA19-9 | |||||||||||
| DCP | |||||||||||
| Present case | 45 | M | AFP | + | - | + | 7 × 5 | Chondrosarcoma, osteosarcoma, spindle cells, and bizarre cells | Segmentectomy | Diaphragm | 7 mo, alive |
| CA 12-5 |
AFP: Alfa-fetoprotein; CA19-9: Carbohydrate antigen 19-9; CEA: Carcinoembryonic antigen; DCP: Des-γ-carboxy prothrombin; HBV: Hepatitis B virus; HCV: Hepatitis C virus; NA: Not available; PVTT: Portal vein tumor thrombus.